A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaChan Y. Cheah, John F. Seymour, Kate Burbury et al.|British Journal of Cancer|2014Cited by 132
A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemiaSimon He, Andrew W. Roberts, Samantha J. Busfield et al.|Leukemia & lymphoma/Leukemia and lymphoma|2014Cited by 126
A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy, in Subjects with B-Cell MalignanciesMichael Dickinson, Brian T. Hill, Nada Hamad et al.|Blood|2021Cited by 19
IL-6–mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantationPing Zhang, Siok‐Keen Tey, Peter Fleming et al.|Journal of Clinical Investigation|2024Cited by 11
Early Cytomegalovirus Reactivation after Allogenic Bone Marrow Transplantation Is Associated with the Loss of Recipient-Derived Humoral Immunity and Is Reduced By IL-6 InhibitionPing Zhang, Siok‐Keen Tey, Peter Fleming et al.|Blood|2021Cited by 1